Another study observed that the expression of Girdin associated with PI3K-Akt signaling, actin remodeling, motility and invasion varies among tumors, and the majority of them have failed to make a transition into cancer clinics as prognostic biomarkers (7). This evidence concerns the gene AKT1 and cancer.